Categories
Politics

Covid nonetheless weighing on jobs however confidence is coming again

Labor Secretary Marty Walsh said Friday that the Covid-19 pandemic is still weighing on jobs, but he forecasted optimism about the recovery of the US economy as vaccinations continue, saying, “We are seeing confidence return. “

Walsh’s comments on CNBC’s “Squawk on the Street” came shortly after the Labor Department released a disappointing April job report showing the non-farm workforce rose by 266,000. Analysts had expected more than 1 million new jobs.

“Under normal circumstances – and we certainly do not live under normal circumstances – a monthly job gain of 266,000 is a good number,” said Walsh. “Unfortunately we are still in the middle of a pandemic.”

“If you look back on the past three months, the US economy has created 500,000 new jobs a month, compared to the last three months when it was 60,000. So we’re definitely going in the right direction, but we still have one There’s no question about it. We’re still facing a pandemic, “Walsh said.

Walsh rejected arguments by Republican lawmakers and corporate groups that federal pandemic unemployment benefits encourage potential workers to stay on the sidelines.

“I still think we need unemployment, obviously we still have millions of Americans out of work. Many of those Americans have no prospects right now,” said Walsh. “I know we are making a correlation between job vacancies and unemployed people, but it’s not a fair correlation.”

Walsh cited data from the job report showing that more Americans were looking for work in April than in previous months.

“I think if we go further here hopefully in the coming months we’ll see a lot of Americans looking for jobs to find work and I’ll be able to stand in front of that camera and talk about us have made big profits, “said Walsh. “But I still think 266,000 jobs this month is a good number.”

Shortly after the job report was released, the Chamber of Commerce issued a statement calling for an end to $ 300 a week of unemployment benefits. Neil Bradley, executive vice president of the group, said the “disappointing job report shows that paying people who don’t work is dampening the stronger job market.”

President Joe Biden said at a news conference that afternoon that the added benefits did not cause a labor shortage.

Walsh, a Democrat and former Boston mayor, said reducing the rise in unemployment is no novice.

“There are millions of Americans affected by the coronavirus who have lost their jobs. Some of their work is not coming back,” he said. “We lost restaurants. We lost business. I wouldn’t say we are in the middle of a pandemic … but we are still alive and dealing with the pandemic and if we move forward here we will continue to recover . “

Barriers to potential workers include the lack of childcare facilities and schools that remain closed, according to Walsh.

“These are currently two barriers I think are keeping people out of the workforce because their children are at home, studying remotely, or their childcare facility is not open,” said Walsh. “The President has made investments in these areas, but we need to keep making those investments so that people feel like they can go back to work.”

Walsh said there were other reasons Americans had not returned to work at the level analysts expected – that it couldn’t be reduced to a single explanation.

“It’s not an easy answer,” he said.

Categories
Business

Confidence within the security of the J&J vaccine is low following U.S. pause, Kaiser survey reveals

An Army nurse holds a vial of the Johnson & Johnson vaccine at the FEMA-sponsored COVID-19 vaccination site at Valencia State College on the first day the site provided the Johnson & Johnson vaccine after the FDA repealed The CDC has offered a break again due to blood clot concerns.

Paul Hennessy | LightRocket | Getty Images

According to a new survey by the Kaiser Family Foundation, less than half of Americans believe the Johnson & Johnson Covid-19 vaccine is safe after it was temporarily suspended in the US after reports of rare blood clotting problems in some recipients.

While most people believe in Covid vaccines, in general, only 46% of respondents said they were at least somewhat confident about the J&J inclusion, compared to 69% who were for both Pfizer and the Moderna vaccines said. Kaiser surveyed 2,097 randomly selected adults aged 18 and over from April 15 to 29 for the study published on Wednesday.

The Food and Drug Administration and Centers for Disease Control and Prevention urged states on April 13 to temporarily stop using J & J’s vaccine “out of caution” after six women reported rare blood clots. A CDC panel recommended the US resume the vaccine ten days later, saying the benefits outweigh the risks.

The J&J news seems to have changed some opinions about a shot.

One in five non-vaccinated respondents said the news changed their minds about receiving the vaccine, even though the specific responses were different. 7% said they were less likely to want any of the three Covid vaccines, Kaiser noted. Another 9% said they were less likely to want the J&J vaccine, but that it didn’t change their mind about the Pfizer or Moderna shots.

Nevertheless, the proportion of respondents who said they had received a shot rose significantly from 32% to 56% in the survey last month. That number reflects data from the CDC, which reports that roughly the same proportion of adults in the United States have received one or more doses.

“The news was widespread and it certainly hurt confidence in J&J, but it’s not clear that it had much of an impact on whether or not people were actually vaccinated,” said Dr. Mollyann Brodie, General Manager of Public Opinion and Survey Research at the Foundation Program. “It confirmed for people who were concerned about side effects that there were side effects, but we know that the immediate effect – at least in terms of what people told us – is very small in terms of demand.”

Women were more likely than men to say the J&J news had changed their minds about vaccination. The Kaiser survey found that Hispanic women in particular, 18% of whom said they were less likely to want a vaccine at all.

The timing of the Johnson & Johnson hiatus coincides with a general slowdown in US vaccinations. The country reported an average of 2.1 million vaccinations per day for the past week, CDC data shows, up from a high of 3.4 million on April 13.

The fact that the nationwide drop in daily shots occurred during the stop is more a coincidence than a direct effect, said Dr. Rupali Limaye, faculty member at the Johns Hopkins Bloomberg School of Public Health. Limaye is researching vaccine decision-making and has worked with state health departments during the vaccine launch.

While the hiatus at J&J, and the reluctance it caused, contributed somewhat to the decline, the bigger factor, according to Limaye, is that the country has reached the point where most Americans who want a vaccine have got one.

“I hear from states that not only are things slowing down generally because of J&J, but also slowing down because we have essentially been able to meet the demand,” she said.

The survey data from the Kaiser Foundation confirm this. Respondents who said they were most anxious to get a shot – those who have already been vaccinated or want it as soon as possible – rose only marginally from 61% to 64% in the previous survey in March. The proportion who wanted to “wait and see” before vaccination, who had lost in size, remained roughly the same.

“We are at a stage in the vaccination effort where all the eager people are vaccinated or are about to be vaccinated,” said Brodie. “We are now turning to the reluctant people, with strategies that are required to reach many different people.”

This equates to an 87% decline, which is steeper than the declines Pfizer and Moderna saw from their respective peaks.

Categories
Business

AMC upgraded as ‘Godzilla vs. Kong’ renews confidence in field workplace

AMC Empire 25 in Times Square is open as New York City theaters reopen for the first time in a year after the coronavirus shutdown on March 5, 2021.

Angela Weiss | AFP | Getty Images

“Godzilla vs. Kong” restores confidence in the future of the box office.

The Warner Bros. ‘film, which released the best opening weekend of any movie released during the coronavirus pandemic, “destroys ongoing concerns about the importance of the cinema window and shows a solid path to resurgence,” wrote Eric Wold, an analyst at B. Riley Securities, in a report on Monday.

“Godzilla vs. Kong” signals that consumers are dying to hit theaters for new blockbuster features and suggests that the upcoming summer slate could have similar success.

Wold also switched AMC Entertainment to “Buy” on its Monday listing and raised its price target from $ 7 to $ 13. The company’s shares rose more than 15% on Monday and have risen more than 410% since January, partly due to renewed confidence in the company’s ability to weather the remainder of the pandemic. AMC has a market value of $ 4.2 billion.

“We remain impressed with the management’s ability to weather the pandemic headwinds by both strengthening the bottom line and negotiating with landlords to improve the runway by 2022,” he wrote. “And as the largest exhibitor in North America that also operates most of the premium IMAX screens, we see AMC as well-positioned to benefit from the forecast industry recovery and to match pre-pandemic visitor numbers by 2023.”

AMC has been hit by the pandemic. The company was already in debt to acquiring smaller theater chains and adding luxury seating to its existing locations. Closures, capacity constraints, and the lack of new movie releases put a significant strain on the company’s finances.

The performance of “Godzilla vs. Kong” is a bright light for AMC and the rest of the cinema industry.

The film, which debuted domestically on Wednesday and released on HBO Max, grossed $ 32.2 million on Friday, Saturday and Sunday and brought in $ 48.5 million for the entire five-day Easter weekend in the US and Canada a.

“We believe consumers want to leave the house and return to the theater, and these results are very telling, especially considering the film was available for free to HBO Max subscribers at the same time it opened in theaters,” Wold wrote.

Notably, less than 60% of the North American theater base was open on weekends, and theater capacity constraints remain between 25% and 50%.

“We think these results are impressive considering the previous movie, Godzilla: King of the Monsters, opened for just $ 47.8 million in May 2019 (all theaters are open with no capacity restrictions) “wrote Wold.

Categories
Business

United Airways buys 25 extra Boeing 737 Max jets in vote of confidence

A United Airlines Boeing 737 Max 9 aircraft lands at San Francisco International Airport.

Justin Sullivan | Getty Images

United Airlines is buying 25 additional Boeing 737 Max planes and taking other orders ahead of schedule in preparation for a rebound in travel demand, the airline said on Monday.

“As we plan for the future and the return of demand, we have looked for ways to best position our fleet for recreation and to be able to best capitalize on people’s desire to travel,” said Andrew Nocella. Chief Commercial by United Officer said in a note to staff.

In addition to the 25 Boeing 737 Max planes slated for delivery in 2023, the Chicago-based airline has increased deliveries of 40 more Max jets by 2022 and five more by 2023. In total, United has firm commitments for 188 maxes, according to a securities filing on Monday.

The vote of confidence in the jetliner comes just months after the Federal Aviation Administration lifted its aircraft ban after two fatal crashes. United, which had 14 Boeing Max 9 jets in its fleet at the time of landing in March 2019, received the planes again in December from Boeing, the first airline to do so. Commercial flights were launched with these jets last month.

United lost more than $ 7 billion last year as it, like other airlines, struggled with the Covid-19 pandemic. The demand for travel is likely to remain weak in the first half of the year. United said in the filing that it expects its capacity to decrease by at least 51% in the first quarter from the same quarter of 2019.

But the airline is now preparing for a recovery as vaccine distribution increases.

“And as the end of the pandemic draws nearer and vaccines continue to expand, today’s fleet announcement will help us meet expected demand in 2022 and 2023 and enable us to offer our employees more opportunities in the future . ” “wrote Nocella.

Boeing stock rose 5.8% on Monday to close at $ 224.39 while United stock rose 1.2% to $ 53.31 during a broad stock market rally.